Review: Somatic mutations in neurodegeneration.

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Somatic mutations, causing mosaicism, are well-known in cancer but are now being investigated in general health and other diseases.
• Advances in sequencing technologies, like single-cell sequencing, enable detailed study of somatic mutations.
• Mosaicism is common in the human body, including the brain, potentially arising during development or aging.

Purpose of the Study:

• To review theoretical considerations and evidence for somatic mutations in the brain.
• To integrate somatic mutations with neurodegeneration, particularly sporadic late-onset diseases.
• To discuss the role of mosaicism in inherited neurodegenerative disorders.

Main Methods:

• Review of existing literature on somatic mutations and neurodegenerative diseases.
• Focus on sporadic late-onset neurodegenerative diseases (Parkinson's, Alzheimer's, ALS).
• Discussion of somatic instability of tandem repeats in inherited disorders.

Main Results:

• Early evidence suggests a role for somatic mutations in Alzheimer's disease.
• Mosaicism is proposed to be common in the normal brain, originating in early development or aging.
• A model is presented linking somatic mutation timing and distribution to disease onset.

Conclusions:

• Somatic mutations and mosaicism are relevant to neurodegeneration.
• The origin and distribution of somatic mutations, alongside risk factors, may influence sporadic neurodegenerative disease development and onset.
• Further research is needed to fully elucidate the role of somatic mutations in brain health and disease.